Drugs / Combined inactivated hepatitis A & recombinant hepatitis B
Combined inactivated hepatitis A & recombinant hepatitis B
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01453348 Comparator | Oct 2011 → Jan 2012 | hepatitis A virus infection, hepatitis B virus infection, meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Combined inactivated hepatitis A & recombinant hepatitis B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01453348 ↗ |
| Modality | Vaccine | “Combined inactivated hepatitis A and recombinant hepatitis B vaccine” NCT01453348 ↗ |
| Route | Intramuscular | “administered by IM” NCT01453348 ↗ |